National Agri-Food Biotechnology Institute (NABI), Mohali, is an autonomous R&D Institute under Department of Biotechnology, Government of India. The institute is establishing a state of art facility in the area of genomics (ABI 3730xl, RT-PCR, DNA analyzer, bioanalyzer, liquid handling system, automated DNA extraction system, LCM, Mass-Array (sequenom), etc), proteomics (MALDI-TOF-TOF, Q-TOF, nano-LC, HPLC, GCMS-MS, HP-TLC, UPLC, etc.), high performance computing facility, and food science (NIR, FTIR, SEM, etc.).The institute carries out cutting edge research at the interface of agricultural biotechnology, bioinformatics, food processing, and nutritional sciences.
Allergan plc and Adamas Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved a new, expanded label for NAMZARIC® (memantine and donepezil hydrochlorides) extended-release, a once-daily, fixed-dose combination of memantine hydrochloride (a NMDA receptor antagonist) and donepezil hydrochloride (an acetylcholinesterase inhibitor, AChEI).

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.
